Valneva Financial Statements From 2010 to 2025
| VLA Stock | EUR 3.21 0.04 1.26% |
Check Valneva SE financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Valneva SE's main balance sheet or income statement drivers, such as , as well as many indicators such as . Valneva financial statements analysis is a perfect complement when working with Valneva SE Valuation or Volatility modules.
Valneva |
Valneva SE Company Return On Equity Analysis
Valneva SE's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Valneva SE Return On Equity | -1.86 |
Most of Valneva SE's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Valneva SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Valneva SE has a Return On Equity of -1.8614. This is much lower than that of the sector and significantly lower than that of the Return On Equity industry. The return on equity for all Austria stocks is notably higher than that of the company.
Valneva SE Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Valneva SE's current stock value. Our valuation model uses many indicators to compare Valneva SE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Valneva SE competition to find correlations between indicators driving Valneva SE's intrinsic value. More Info.Valneva SE is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Valneva SE by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Valneva SE's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Valneva SE Financial Statements
Investors use fundamental indicators, such as Valneva SE's revenue or net income, to determine how well the company is positioned to perform in the future. Although Valneva SE's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Valneva SE, a biotech company, engages in developing and commercializing vaccines for infectious diseases with unmet needs. It has operations in Austria, Sweden, the United Kingdom, France, Canada, and the United States. VALNEVA SE is traded on Vienna Stock Exchange in Austria.
Currently Active Assets on Macroaxis
Other Information on Investing in Valneva Stock
Valneva SE financial ratios help investors to determine whether Valneva Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valneva with respect to the benefits of owning Valneva SE security.